Anest. intenziv. Med. 2016;27(4):228-236

A few comments by clinical biochemists on acute kidney injuryIntesive Care Medicine - Special Article

A. Jabor1,2,*, J. Franeková1,2
1 Pracoviště laboratorních metod, IKEM, Praha
2 3. lékařská fakulta, Univerzita Karlova, Praha

This review paper addresses the definition of acute kidney injury and other related nosologic units, criteria of function, and the RIFLE and AKIN classifications. The new clinical unit called subclinical acute kidney injury as well as kidney damage biomarkers are also focused on. Difficulties related to the examination of the kidney function - together with suggested solutions - are dealt with, e. g. the issue of measuring and estimating glomerular filtration rate (GFR), the issue of comparability and traceability of creatinine, urea, and cystatin C measurements in the serum, the issue of comparability of different estimated GFR values including the use of GFR estimation in intensive care, the issue of baseline serum creatinine, the influence of biological variability on interpretation, and finally, the issue of choosing and measuring the biomarkers of kidney injury.

Keywords: acute kidney injury network (AKIN); acute kidney injury (AKI); acute kidney disease (AKD); chronic kidney disease (CKD); glomerular filtration rate (GFR); Kidney Disease, Improving Global Outcome (KDIGO); Neutrophil gelatinase-associated lipocalin (NGAL); Risk, Injury, Failure, Loss-of-function, End-stage renal disease (RIFLE)

Received: October 23, 2015; Accepted: November 27, 2015; Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jabor A, Franeková J. A few comments by clinical biochemists on acute kidney injury. Anest. intenziv. Med. 2016;27(4):228-236.
Download citation

References

  1. KDIGO CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl., 2013, 3, p. 1-150.
  2. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. Suppl., 2012, 2, p. 1-138.
  3. Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G. et al. Acute Kidney Injury Network: report of a initiative to improve outcomes in acute kidney injury. Crit Care, 2007, 11, R31. Go to original source... Go to PubMed...
  4. Ronco, C. ADQI Consensus on AKI Biomarkers and Cardiorenal Syndromes. Contrib. Nephrol. Basel Karger, 2013, 182, p. 5-12. Go to PubMed...
  5. Haase, M., Devarajan, P., Haase-Fielitz, A., Bellomo, R., Cruz, D. N., Wagener, G. et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J. Am. Coll. Cardiol., 2011, 57, 17, p. 1752-1761. Go to original source... Go to PubMed...
  6. Ho, J., Tangri, N., Komenda, P., Kaushal, A., Sood, M., Brar, R. et al. Urinary, Plasma, and Serum Biomarkers' Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis. Am. J. Kidney Dis., 2015, pii: S0272-6386(15)00940-3. doi: 10.1053/j.ajkd.2015.06.018. [Epub ahead of print]. Go to original source... Go to PubMed...
  7. Urbschat, A., Obermüller, N., Haferkamp, A. Biomarkers of kidney injury. Biomarkers, 2011, 16 Suppl 1, S22-30. Go to original source... Go to PubMed...
  8. Vanmassenhove, J., Vanholder, R., Nagler, E., Van Biesen, W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol. Dial. Transplant., 2013, 28, 2, p. 254-273. Go to original source... Go to PubMed...
  9. McCullough, P. A., Kellum, J. A., Haase, M., Muller, C., Damman, K., Murray, P. T. et al. Pathophysiology of the Cardiorenal Syndromes: Executive Summary from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Blood Purif., 2014, 37, suppl, p. 2-13. Go to original source... Go to PubMed...
  10. Bagshaw, S. M., Bennett, M., Haase, M., Haase-Fielitz, A., Egi, M., Morimatsu, H. et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med., 2010, 36, 3, p. 452-461. Go to original source... Go to PubMed...
  11. Matsa, R., Ashley, E., Sharma, V., Walden, A. P., Keating. L. Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients. Crit Care, 2014, 18:R137. Go to original source... Go to PubMed...
  12. Haase, M., Bellomo, R., Devarajan, P., Schlattmann, P., Haase-Fielitz, A. NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis., 2009, 54, 6, p. 1012-1024. Go to original source... Go to PubMed...
  13. Haase-Fielitz, A., Haase, M., Devarajan, P. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann. Clin. Biochem., 2014, 51, Pt 3, p. 335-351. Go to original source... Go to PubMed...
  14. Ronco, C. Biomarkers for acute kidney injury: is NGAL ready for clinical use? Crit. Care, 2014, 18:680. Go to original source... Go to PubMed...
  15. Soveri, I., Berg, U. B., Björk, J., Elinder, C. G., Grubb, A., Mejare, I. et al. Measuring GFR: a systematic review. Am. J. Kidney Dis., 2014, 64, p. 411-424. Go to original source... Go to PubMed...
  16. Sečník, P., Franeková, J., Komínková, M., Kotrbatý, J., Hunal, Z., Tlučhořová, D. et al. Interference dobutaminu při stanovení analytů s využitím Trinderovy reakce. Klinická biochemie a metabolismus, 2012, 20, 41, 1, p. 17-30.
  17. Jaffé, M. Über den Niederschlag, welchen Pikrinsäure in normalen Harn erzeugt und über eine neue Reaction des Kreatinins. Z Physiol Chem., 1886, 10, p. 391-400. Go to original source...
  18. Cockcroft, D. W., Gault, M. H. Prediction of creatinine clearance from serum creatinine. Nephron., 1976, 16, p. 31-41. Go to original source... Go to PubMed...
  19. Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. L., Castro, A. F. 3rd, Feldman, H. I. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med., 2009, 150, p. 604-612. Go to original source... Go to PubMed...
  20. Grubb, A., Nyman, U., Björk, J., Lindström, V., Rippe, B., Sterner, G. et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin. Chem., 2005, 51, p. 1420-1431. Go to original source... Go to PubMed...
  21. Grubb, A., Horio, M., Hansson, L. O., Björk, J., Nyman, U., Flodin, M. et al. Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin. Chem., 2014, 60, p. 974-986. Go to original source... Go to PubMed...
  22. Delanaye, P., Cavalier, E., Morel, J., Mehdi, M., Maillard, N., Claisse, G. et al. Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine. BMC Nephrol., 2014, 15, 9. Go to original source... Go to PubMed...
  23. Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P. Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care, 2004, 8, R204-212. Go to original source... Go to PubMed...
  24. Jabor, A., Franeková, J. Principy interpretace laboratorních testů. Roche: Praha 2013, ISBN 978-80-260-5094-0.
  25. American Diabetes Association (ADA). Standards of Medical Care in Diabetes-2015. Diabetes Care, 2015, 38, Suppl. 1, S1-S93. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.